Arizona Gold & Silver Inc V.AZS

Pinnacle Digest. The best time to buy the TSXV

[winr88]

The Best Time to Buy the TSX Venture is Here

 

In many respects, 2021 was a banner year for the TSX Venture as it regained some of its form from nearly a decade ago when capital was flowing across the exchange. This year, daily trading volume pushed up against the 100 million shares average mark for the first time since 2014 (roughly 94 million shares have exchanged hands daily on the exchange through November). Additionally, the TSX Venture Index hit an 8-year high of just over 1,113 in February 2021.

 

 

This year, volatility on the Venture was well below its decade average. Measuring volatility based on the TSX Venture Index’s swing from peak to trough, 2021’s 24% swing is well below the ten-year average of approximately 33.75%.

 

 

In my view, the most critical health gauge of the TSXV is capital raised. Healthy company treasuries lead to fundamental business development, revenue growth, mineral discoveries and other material events. This is another reason for optimism among speculators as we head into 2022...

 

 

There was a record level of financings achieved from Venture issuers through Q3, 2021. Cumulatively, TSX Venture-listed companies averaged roughly CAD$1 billion per month in capital raises during the year's first nine months. It has since dropped off substantially, but that's not a surprise given the weak seasonality factors at play in Q4.

 

 

I believe Q4's drop in financing capital raised is a blip on the radar -not a trend.

 

Sector Interest Has Changed, But Momentum is Intact

In my annual year-end letter last year, I noted,

 

“The TSX Venture is enjoying a speculative buying frenzy across multiple markets. I haven’t seen this level of speculation on the Venture in a long time. And I can’t remember ever seeing it across so many sectors. From health and wellness to gaming, psychedelics, and even cannabis and gold – speculators are bidding up TSX Venture and CSE-listed deals.”

 

 

Although the ‘hot’ sectors have changed from last year, the theme is similar: speculative growth opportunities remain in demand, and the Canadian small-cap indices benefit.

 

 

Today, I’m going to explain why we could be embarking on another very opportune time for Venture investors -- at least over the short term.

 

December 22nd is an Important Date for the TSX Venture

Long-time readers will remember my extensive research on TSX Venture seasonality factors. According to this research, the best time to buy the TSX Venture has historically been December 22nd — give or take a few days.

 

 

Why?

 

 

For the past eighteen years, on average, the TSX Venture has increased approximately 13.85% within 60 days following December 22nd. In a third of those years, the highest level hit for the Venture during those 60 days came in January (2008, 2010, 2013, 2015, 2018, and 2020).

 

 

Keep in mind, however, that the timing of this phenomenon is variable. For example, in 2018, the Venture rose from 530.20 on December 21, 2018 to 625.26 on February 4, 2019. Following December 22, 2016, the high within the next 60 days occurred on the final day, February 22, 2017.

 

 

This year, the Venture once again peaked on the final day of the 60 day period, February 22, 2021. That day also marked the Venture's high for the entire year. From December 22, 2020, to February 22, 2021, the TSXV gained roughly 34%! Q1 was incredible from a valuation and liquidity perspective.

 

 

In summary, if you could buy the TSX Venture Index on December 22nd (give or take a day) over the past eighteen years, you would have had the opportunity to sell within the next 60 days for a handsome profit — 100% of the time.

 

 

Take a look at the chart below, which illustrates the potential gains within this coming 60-day period for the last eighteen years:

This chart is for illustrative purposes only and not indicative of any actual investment. These returns were the result of certain market factors and events which may not be repeated in the future. Past performance is no guarantee of future results.

 

Wrapping Up

The TSX Venture and Canada’s small and micro-cap markets most certainly got their footing re-established this year. Financings, trading volume, and valuations were all up to multi-year – if not all-time – highs. Additionally, volatility was below its decade average as the TSXV has gone from a one or two-trick pony index (mining and cannabis), to a diversified exchange for startups, with representation across multiple sectors including crypto, mining, energy, technology, cannabis, life sciences and more.

 

 

With December 22nd just a few days away, if you haven’t already begun looking for opportunities across Canada’s ever diversifying small and micro-cap markets, take a closer look before the holiday break. The tax-loss selling season is nearly done, and we’re entering the most historically bullish season for the TSXV.

 

Wishing you a Merry Christmas and a wonderful holiday season with your loved ones,

 

 

Aaron

 

PINNACLEDIGEST.COM

Sponsored: Small-Cap News

Entheon Biomedical Announces EEG Patent Application & Provides Research Update Excerpt: "...The patent relates to improved technology for detection and maintenance of the optimal therapeutic psychedelic state, which Entheon intends to study through the monitoring of electroencephalogram (EEG) biomarkers in order to optimize the treatment of neuropsychiatric conditions...”   Click here to read full release.

December's Stock Challenge Standings

Click image to view the current standings.

 

Click here to sign up for Stock Challenge.

The Stock Challenge Index (SCI) tracks the average return of every contestant in the Stock Challenge over a 1-month period.

 

Disclosure, Compensation, Risks Involved and Forward-Looking Statements: 

 

Please read carefully before proceeding.

 

THIS IS NOT INVESTMENT ADVICE. All statements in this report are to be checked and verified by the reader. This report may contain technical or other inaccuracies, omissions, or typographical errors, for which Maximus Strategic Consulting Inc., owner of PinnacleDigest.com, assumes no responsibility. 

 

All statements in this report, other than statements of historical fact, should be considered forward-looking statements. These statements relate to future events or future performance. 

 

Forward-looking statements are often, but not always identified by the use of words such as "seek", "anticipate", "plan", "continue", "estimate", "expect", "may", "will", "project", "predict", "potential", "targeting", "intend", "could", "might", "should", "believe", "budget", "scheduled", and similar expressions. Much of this report is comprised of statements of projection. These statements involve known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking statements.

 

Be advised, Maximus Strategic Consulting Inc. ("Maximus" or "we" or "Pinnacle Digest" or "PinnacleDigest.com") and its employees/consultants are not a registered broker-dealer or financial advisors. Before investing in any securities, you should consult with your financial advisor and a registered broker-dealer.

 

PinnacleDigest.com is an online financial newsletter owned by Maximus Strategic Consulting Inc. We are focused on researching and marketing for small public companies. Nothing in this report should be construed as a solicitation to buy or sell any securities mentioned anywhere in this report. This report is intended for informational and entertainment purposes only. The author of this report, and its publishers, bear no liability for losses and/or damages arising from the use of this report.

 

Never, ever, make an investment based solely on what you read in an online newsletter, including Pinnacle Digest's online newsletter, or internet bulletin board, especially if the investment involves a small, thinly-traded company that isn't well known. 

 

Most companies featured in the Pinnacle Digest newsletter, and on our website, are paying clients of ours (including Entheon Biomedical Corp. -- details in this disclaimer). In many cases, we own shares in the companies we feature and advertise for. For those reasons, please be aware that we are extremely biased in regards to the companies we write about and feature in our newsletter and on our website. 

 

Because we are paid by public companies to provide our online advertising and marketing services, and we may own shares in the companies mentioned in our newsletter, you must recognize the inherent conflict of interest involved that may influence our perspective on these companies; this is one reason why we stress that you conduct extensive due diligence as well as seek the advice of your financial advisor and a registered broker-dealer before investing in any securities mentioned in our reports.  

 

Maximus, its officers, directors, employees, and consultants shall not be liable for any damages, losses, or costs of any kind or type arising out of or in any way connected with the use of its products or services, including this report. Maximus, its employees, consultants and affiliates are not responsible for any claims made by any of the mentioned companies or third party writers in this report. 

 

You should independently investigate and fully understand all risks before investing. We want to remind you again that PinnacleDigest.com is often paid editorial fees for its writing and the dissemination of material. The clients represented by PinnacleDigest.com are typically exploration-stage or development-stage companies that pose a much higher risk to investors than established companies. When investing in speculative stocks of this nature, it is possible to lose your entire investment over time or even quickly. 

 

Set forth below is our disclosure of compensation received from all of our clients mentioned in this newsletter:

 

Maximus Strategic Consulting Inc., owner of PinnacleDigest.com, has been paid CAD$150,000 plus GST to provide online advertisement coverage for Entheon Biomedical Corp. (“Entheon”) for a six-month online marketing agreement. Entheon paid for this coverage. The coverage includes, but is not limited to, the production and distribution of a video about Entheon, as well as display advertisements and news distribution about Entheon on our website and in our newsletter. We (Maximus Strategic Consulting Inc.) may purchase shares of Entheon in the future. Any shares we may purchase in the future of Entheon will be sold without notice to PinnacleDigest.com’s subscribers. Please recognize that Maximus Strategic Consulting Inc. may benefit from price and trading volume increases in Entheon. Because Entheon has paid us for our online marketing and advertising services, you must recognize the inherent conflict of interest involved that may influence our perspective on Entheon. Because we are paid by Entheon, and therefore we are not independent reporters, our coverage of Entheon features many of its positive aspects, and not the potential risks to its business or to investing in its stock.

 

 

PinnacleDigest.com's past performance is not indicative of future results and should not be used as a reason to purchase any security mentioned in this report, on our website or in future Pinnacle Digest newsletters. 

 

Maximus Strategic Consulting Inc. and PinnacleDigest.com (including its employees and consultants) are not chartered business valuators; the methods used by business valuators often cannot justify any trading price for most junior stock exchange listed companies. Entheon Biomedical Corp. is a junior stock exchange listed company.

 

All information in this report regarding publicly traded companies' market caps, stock prices and trading information was sourced from Quotemedia or Bloomberg. There are no guarantees that these figures are accurate or complete. 

 

Any decision to purchase or sell as a result of the opinions expressed in this report OR ON PinnacleDigest.com will be the full responsibility of the person authorizing such transaction, and should only be made after such person has consulted a registered financial advisor and conducted thorough due diligence. 

 

Information in this report has been obtained from sources considered to be reliable, but we do not guarantee that it is accurate or complete. Our views and opinions regarding the companies we feature on PinnacleDigest.com and in this report are our own views and are based on information that we have received, which we assumed to be reliable. We do not guarantee that any of the companies mentioned in this report or on PinnacleDigest.com will perform as we expect, and any comparisons we have made to other companies may not be valid or come into effect.

 

To get an up to date account on any changes to our Privacy Policy please click here.

   

Maximus Strategic Consulting Inc., owner of PinnacleDigest.com, does not undertake any obligation to publicly update or revise any statements made in this report.

 

Learn how to protect yourself and become a more informed investor at www.investright.org 

 

Please be aware and note the date on which this report was published. As a result of the passing of time, the relevancy of the opinions and facts in this report are likely to diminish over time and may change without an update to the report. As such, you cannot rely on the accuracy and timeliness of the information provided and should consider this report irrelevant after an extended period of time from the date which it was published. Since there is no specific guideline as to how long a report may remain relevant, you should consider that this report may be irrelevant shortly after it was published.

 

Thank you for reading.